← Leaderboards
Axel Visel
University Of Calif-Lawrenc Berkeley Lab
$21,110,425
Attributed
$32,699,188
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,699,188 · 10
By mechanism
R01$11,858,178 · 5
UM1$11,184,235 · 2
U01$5,763,829 · 2
R24$3,892,946 · 1
Top collaborators
- Len Alexander Pennacchio22 shared
- William T Pu5 shared
- Christine E. Seidman5 shared
- Jonathan G Seidman5 shared
Most similar at University Of Calif-Lawrenc Berkeley Lab
Same institution · by research overlap
- Len Alexander Pennacchio$35,353,607
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoTissuesVariantGene ExpressionGenesEnhancersMapsGeneticReporterUntranslated RnaGenomicsPhenotypeDistantHuman GeneticsData SetTransgenic MiceResourcesTransgenic OrganismsHuman GenomeTranscriptome SequencingInsightResolutionLinkResearch Personnel
Grant awards (41)
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$816,577
R01 · FY2025 · HD
Single-Cell-Resolved Mapping and Evolution-Driven Functional Interrogation of Human Midface Enhancers$804,478
R01 · FY2025 · DE · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$749,365
R01 · FY2025 · HL · contact PI
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$808,412
R01 · FY2024 · HD
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$734,378
R01 · FY2024 · HL · contact PI
Evaluating the Impact of Mutations in Distant-Acting Enhancers in Structural Birth Defects$816,999
R01 · FY2023 · HD
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development$798,040
R01 · FY2023 · DE · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$749,289
R01 · FY2023 · HL · contact PI
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development$829,174
R01 · FY2022 · DE · contact PI
In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease$765,868
R01 · FY2022 · HL · contact PI
Linking Psychiatric Genetics to Cell-Type Specific Enhancer Function$719,059
R01 · FY2022 · MH · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,358,777
UM1 · FY2021 · HG
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development$837,596
R01 · FY2021 · DE · contact PI
Linking Psychiatric Genetics to Cell-Type Specific Enhancer Function$719,059
R01 · FY2021 · MH · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2020 · HG
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development$852,357
R01 · FY2020 · DE · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2019 · HG
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2019 · HL
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development$857,527
R01 · FY2019 · DE · contact PI
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2019 · HL · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2018 · HG
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2018 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2018 · HL · contact PI
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies$753,793
U01 · FY2018 · DE · contact PI
In Vivo Characterization of Major ENCODE-Predicted Classes of Noncoding Elements$1,348,257
UM1 · FY2017 · HG
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2017 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$778,308
R24 · FY2017 · HL · contact PI
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies$638,909
U01 · FY2017 · DE · contact PI
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies$340,689
U01 · FY2017 · DE · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2016 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$779,011
R24 · FY2016 · HL · contact PI
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies$638,909
U01 · FY2016 · DE · contact PI
Regulation of Cardiac Development in Health and Disease$914,286
UM1 · FY2015 · HL
Genome-Wide Resources for Transcriptional Enhancers Active in the Human Heart$779,011
R24 · FY2015 · HL · contact PI
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies$638,909
U01 · FY2015 · DE · contact PI
GENOMIC AND TRANSGENIC RESOURCES FOR CRANIOFACIAL ENHANCER STUDIES$639,010
U01 · FY2014 · DE · contact PI
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers$399,021
U01 · FY2013 · DE · contact PI
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers$411,362
U01 · FY2012 · DE · contact PI
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers$433,130
U01 · FY2011 · DE · contact PI
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers$426,475
U01 · FY2010 · DE · contact PI
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers$443,622
U01 · FY2009 · DE · contact PI